Compare NECB & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NECB | OSUR |
|---|---|---|
| Founded | 1934 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.4M | 174.3M |
| IPO Year | N/A | 1986 |
| Metric | NECB | OSUR |
|---|---|---|
| Price | $22.73 | $2.38 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 48.7K | ★ 673.9K |
| Earning Date | 01-28-2026 | 02-24-2026 |
| Dividend Yield | ★ 4.39% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.21 | N/A |
| Revenue | $102,569,000.00 | ★ $125,703,000.00 |
| Revenue This Year | $1.90 | N/A |
| Revenue Next Year | $6.93 | $3.70 |
| P/E Ratio | $7.09 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $19.27 | $2.08 |
| 52 Week High | $25.93 | $4.22 |
| Indicator | NECB | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 54.59 | 43.20 |
| Support Level | $22.79 | $2.41 |
| Resistance Level | $23.11 | $2.50 |
| Average True Range (ATR) | 0.54 | 0.09 |
| MACD | -0.17 | 0.00 |
| Stochastic Oscillator | 28.75 | 18.00 |
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.